Tissue Culture Shared Resource

Home | Services & Fees | Educational Resources | Publications | Schedule


2003 2004 2005 2006 2007 2008 2009 2010 2011 2012


Bae, I., J. K. Rih, H. J. Kim, H. J. Kang, B. Haddad, A. Kirilyuk, S. Fan, M. L. Avantaggiati, and E. M. Rosen. 2005. BRCA1 regulates gene expression for orderly mitotic progression. Cell Cycle 4:1641-1666.

Bouker, K. B., T. C. Skaar, R. B. Riggins, D. S. Harburger, D. R. Fernandez, A. Zwart, A. Wang, and R. Clarke. 2005. Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis. Carcinogenesis 26:1527-1535.

Chen, T., Y. Pengetnze, and C. C. Taylor. 2005. Src inhibition enhances paclitaxel cytotoxicity in ovarian cancer cells by caspase-9-independent activation of caspase-3. Mol Cancer Ther. 4:217-224

Fan, S., M. Gao, Q. Meng, J. J. Laterra, M. H. Symons, S. Coniglio, R. G. Pestell, I. D. Goldberg, and E. M. Rosen. 2005. Role of NF-kappaB signaling in hepatocyte growth factor/scatter factor-mediated cell protection. Oncogene 24:1749-1766.

Fu, M., M. Rao, T. Bouras, C. Wang, K. Wu, X. Zhang, Z. Li, T. P. Yao, and R. G. Pestell. 2005. Cyclin D1 inhibits peroxisome proliferator-activated receptor gamma - mediated adipogenesis through histone deacetylase recruitment. J Biol Chem 280:16934-16941.

Fu, M., C. Wang, M. Rao, X. Wu, T. Bouras, X. Zhang, Z. Li, X. Jiao, J. Yang, A. Li, N. D. Perkins, B. Thimmapaya, A. L. Kung, A. Munoz, A. Giordano, M. P. Lisanti, and R. G. Pestell. 2005. Cyclin D1 represses p300 transactivation through a cyclin-dependent kinase-independent mechanism. J Biol Chem280:29728

George, J. A., T. Chen, and C. C. Taylor. 2005. SRC tyrosine kinase and multidrug resistance protein-1 inhibitions act independently but cooperatively to restore paclitaxel sensitivity to paclitaxel-resistant ovarian cancer cells. Cancer Res 65:10381-10388.

Gedil M.A., N.K. Steiner, C.K. Hurley. 2005. Genomic characterization of KIR2DL4 in families and unrelated individuals reveals extensive diversity in exon and intron sequences including a common frameshift variation occurring in several alleles. Tissue Antigens 65:402-418.

Jin X, Hirosaki T, Lin CY, Dickson RB, Higashi S, Kitamura H, Miyazaki K. 2005. Production of soluble matriptase by human cancer cell lines and cell surface activation of its zymogen by trypsin. J Cell Biochem 95(3):632-647.

Kim BY, Cho CH, Song DK, Mun KC, Suh SI, Kim SP, Shin DH, Jang BC, Kwon TK, Cha SD, Bae I, Bae JH. 2005. Ciglitizone inhibits cell proliferation in human uterine leiomyoma via activation of store-operated Ca2+ channels. Am J Physiol Cell Physiol 288(2):C389-C395.

LeBaron, M. J., J. Xie, and H. Rui. 2005. Evaluation of genome-wide chromatin library of Stat5 binding sites in human breast cancer. Mol Cancer 4(1):6.

Lee JW, Yong SS, Choi JJ, Lee SJ, Kim BG, Park CS, Lee JH, Lin CY, Dickson RB, Bae DS. 2005. Increased expression of matriptase is associated with histopathologic grades of cervical neoplasia. Hum Pathol 36(6):626-633.

Lee MS, Kiyomiya K, Benaud C, Dickson RB, Lin CY. 2005. Simultaneous activation and hepatocyte growth factor activator inhibitor 1-mediated inhibition of matriptase induced at activation foci in human mammary epithelial cells. Am J Physiol Cell Physiol 288(4):C932-C941.

Ma, Y. X., Y. Tomita, S. Fan, K. Wu, Y. Tong, Z. Zhao, L. N. Song, I. D. Goldberg, and E. M. Rosen. 2005. Structural determinants of the BRCA1: estrogen receptor interaction. Oncogene 24:1831-1846.

Meng, Q. H., L. X. Zhou, J. L. Luo, J. P. Cao, J. Tong, and S. J. Fan. 2005. Effect of 7-hydroxystaurosporine on glioblastoma cell invasion and migration. Acta Pharmacol.Sin. 26:492-499.

Oberst, M. D., L. Y. Chen, K. Kiyomiya, C. A. Williams, M. S. Lee, M. D. Johnson, R. B. Dickson, and C. Y. Lin. 2005. HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease. Am J Physiol Cell Physiol 289(2):C462-70.

Park KC, Song KH, Chung HK, Kim H, Kim DW, Song JH, Hwang ES, Jung HS, Park SH, Bae I, Lee IK, Choi HS, Shong M. 2005. CR6-interacting factor 1 interacts with orphan nuclear receptor Nur77 and inhibits its transactivation. Mol Endocrinol 19(1):12-24.

Rae JM, Johnson MD, Scheys JO, Cordero KE, Larios JM, Lippman ME. 2005. GREB 1 is a critical regulator of hormone dependent breast cancer growth. Breast Cancer Res Treat 92(2):141-149.

Ramljak, D., L. J. Romanczyk, L. J. Metheny-Barlow, N. Thompson, V. Knezevic, M. Galperin, A. Ramesh, and R. B. Dickson. 2005. Pentameric procyanidin from Theobroma cacao selectively inhibits growth of human breast cancer cells. Mol Cancer Ther. 4:537-546.

Riggins, R. B., A. H. Bouton, M. C. Liu, and R. Clarke. 2005. Antiestrogens, aromatase inhibitors, and apoptosis in breast cancer. Vitam.Horm. 71:201-237.

Riggins, R. B., A. Zwart, R. Nehra, and R. Clarke. 2005. The nuclear factor kappa B inhibitor parthenolide restores ICI 182,780 (Faslodex; fulvestrant)-induced apoptosis in antiestrogen-resistant breast cancer cells. Mol Cancer Ther. 4:33-41.

Siddiqui SF, Pawelek J, Handerson T, Lin CY, Dickson RB, Rimm DL, Camp RL. 2005. Coexpression of beta1,6-N-acetylglucosaminyltransferase V glycoprotein substrates defines aggressive breast cancers with poor outcome. Cancer Epidemiol Biomarkers Prev 14(11 Pt 1):2517-2523.

Song, L. N. and E. P. Gelmann. 2005. Interaction of beta-catenin and TIF2/GRIP1 in transcriptional activation by the androgen receptor. J Biol Chem 280:37853-37867.

Stoica GE, Franke TF, Wellstein A, Morgan E, Czubayko F, List HJ, Reiter R, Martin MB, Stoica A. 2005. Heregulin-beta1 regulates the estrogen receptor-alpha gene expression and activity via the ErbB2/PI 3-K/Akt pathway. Oncogene 24(11):1964.

Sultan, A. S., J. Xie, M. J. LeBaron, E. L. Ealley, M. T. Nevalainen, and H. Rui. 2005. Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells. Oncogene 24:746-760.

Tirado OM, Mateo-Lozano S, Notario V. 2005. Rapamycin induces apoptosis of JN-DSRCT-1 cells by increasing the Bax : Bcl-xL ratio through concurrent mechanisms dependent and independent of its mTOR inhibitory activity. Oncogene 24(20):3348-3357.

Tirado OM, Mateo-Lozano S, Notario V. 2005. Roscovitine is an effective inducer of apoptosis of Ewing’s sarcoma family tumor cells in vitro and in vivo. Cancer Res 65(20):9320-9327.

Uren, A., S. Fallen, H. Yuan, A. Usubutun, T. Kucukali, R. Schlegel, and J. A. Toretsky. 2005. Activation of the canonical Wnt pathway during genital keratinocyte transformation: a model for cervical cancer progression. Cancer Res 65:6199-6206.

Xu, J., S. Fan, and E. M. Rosen. 2005. Regulation of the estrogen-inducible gene expression profile by the breast cancer susceptibility gene BRCA1. Endocrinology 146:2031-2047.

Zhang, Y., S. Fan, Q. Meng, Y. Ma, P. Katiyar, R. Schlegel, and E. M. Rosen. 2005. BRCA1 interaction with human papillomavirus oncoproteins. J Biol Chem 280:33165-33177.

Zhang, Y., M. Jung, A. Dritschilo, and M. Jung. 2004. Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors. Radiat.Res 161:667-674.